Skip to main content

X-Linked Retinoschisis clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)

    Sorry, in progress, not accepting new patients

    This study will evaluate the safety and efficacy of a recombinant adeno-associated virus vector expressing retinoschisin (rAAV2tYF-CB-hRS1) in patients with X-linked retinoschisis. Up to 27 participants will be enrolled and 3 dose levels will be evaluated in a dose escalation format.

    San Francisco, California and other locations

Our lead scientists for X-Linked Retinoschisis research studies include .

Last updated: